Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?

Area of Science:

• Genetics and Molecular Biology
• Cell Biology
• Biomedical Research

Background:

• Mitochondrial diseases are complex inherited disorders affecting cellular energy production, impacting ~1 in 5000 births.
• These conditions are clinically and genetically diverse, often tissue-specific, particularly affecting high-energy organs like the brain, heart, and kidneys.
• Current treatment options are limited, with few clinically validated therapies despite promising research agents.

Purpose of the Study:

• To catalogue existing human pluripotent stem cell (hPSC) models for mitochondrial diseases.
• To summarize the methodologies and outcomes of phenotypic profiling in these hPSC models.
• To provide guidance for future research utilizing hPSC models in mitochondrial disease studies.

Main Methods:

• Review and cataloguing of established hPSC models for mitochondrial diseases (both nuclear-DNA and mitochondrial-DNA related).
• Summarization of phenotypic characterization approaches applied to these hPSC models.
• Analysis of key findings from phenotypic profiling to understand disease mechanisms.

Main Results:

• Identification and compilation of various hPSC models developed for studying mitochondrial diseases.
• Overview of successful phenotypic investigations using hPSC-derived cells, revealing disease-specific cellular defects.
• Demonstration of hPSC models' utility in dissecting pathomechanisms and evaluating therapeutic strategies.

Conclusions:

• Human pluripotent stem cells provide a versatile platform for modeling the complexity of mitochondrial diseases.
• hPSC models overcome limitations of non-human models and limited patient tissue access, enabling detailed mechanistic studies.
• This work establishes criteria for developing and validating hPSC models, advancing research towards effective treatments for mitochondrial disorders.